MEDEIKON ANNOUNCES ADVANCES IN INTERVENTIONAL CARDIOLOGY

Medeikon Corporation provides medical devices for diagnosis and treatment of cardiovascular disease. Our initial emphasis is on vulnerable plaque, the leading cause of sudden cardiac death. Medeikon's XploraPD system distinguishes these rupture-prone lesions from other types of coronary artery tissue using optical technologies. This allows physicians make early and accurate diagnosis and then treat the condition with tools consistent with current cardiac catheterization techniques and equipment.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1060932XSL_NEWSML_TO_NEWSML_WEB.xml)